Cabio Biotech Wuhan Co Ltd (688089) — Cash Flow Quality Index
Cabio Biotech Wuhan Co Ltd (688089) has a Cash Flow Quality Index of 2.62x as of September 2025. Operating cash flow of CN¥56.10 Million exceeds net income of CN¥21.39 Million, indicating high earnings quality where cash backs reported profits. Also explore Cabio Biotech Wuhan Co Ltd balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cabio Biotech Wuhan Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Cabio Biotech Wuhan Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Cabio Biotech Wuhan Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Cabio Biotech Wuhan Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Cabio Biotech Wuhan Co Ltd. For live market cap and the full company financial profile, see Cabio Biotech Wuhan Co Ltd (688089) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.44x | CN¥173.04 Million | CN¥120.13 Million | ▲ +91.1% |
| 2023 | 0.75x | CN¥68.89 Million | CN¥91.37 Million | ▼ -73.7% |
| 2022 | 2.86x | CN¥176.40 Million | CN¥61.59 Million | ▲ +264.1% |
| 2021 | 0.79x | CN¥103.29 Million | CN¥131.29 Million | ▼ -27.2% |
| 2020 | 1.08x | CN¥145.88 Million | CN¥134.94 Million | ▼ -1.9% |
| 2019 | 1.10x | CN¥131.95 Million | CN¥119.75 Million | ▲ +1.5% |
| 2018 | 1.09x | CN¥106.16 Million | CN¥97.83 Million | ▼ -29.3% |
| 2017 | 1.53x | CN¥100.66 Million | CN¥65.59 Million | ▲ +13.8% |
| 2016 | 1.35x | CN¥62.53 Million | CN¥46.35 Million | ▼ -40.9% |
| 2015 | 2.28x | CN¥44.58 Million | CN¥19.55 Million | ▲ +85.4% |
| 2014 | 1.23x | CN¥46.34 Million | CN¥37.66 Million | ▲ +45.6% |
| 2013 | 0.85x | CN¥39.48 Million | CN¥46.70 Million | — |